Nuvation Bio Inc Class A — Cash Flow (NYSE:NUVB) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities —-68.19 M-96.11 M-68 M-130.41 M -190 M Cash from investing activities —-454.67 M63.46 M8.92 M122.7 M 64.21 M Cash from financing activities —625.53 M1.33 M628 K331 K 193.57 M Free cash flow —-68.47 M-96.48 M-68.07 M-130.57 M -190.25 M

新闻

Regenxbio (RGNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Tracking David Abrams' Abrams Capital Management Portfolio - Q4 2025 Update

Nuvation Bio expands SIGMA trial to phase 3 for IDH1-mutant glioma

Nuvation Bio股票因Ibtrozi销售势头强劲维持B.Riley买入评级

Nuvation Bio stock maintains Buy rating at B.Riley on Ibtrozi sales momentum

Nuvation Bio: Rollout Data Of Ibtrozi Support A Modest Buy (NYSE:NUVB)

Truist Securities上调Nuvation Bio股票目标价至13美元，看好Ibtrozi市场表现

Truist Securities raises Nuvation Bio stock price target to $13 on Ibtrozi uptake

Jones Trading raises Nuvation Bio stock price target to $12 on safusidenib study

Down 24% in 4 Weeks, Here's Why Nuvation Bio (NUVB) Looks Ripe for a Turnaround

H.C. Wainwright下调Nuvation Bio目标价至17美元

Nuvation Bio stock price target lowered to $17 at H.C. Wainwright